These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 19553017)
1. Comment on: excessive opioid use and the development of chronic migraine. Bartley J; Watkins LR Pain; 2009 Sep; 145(1-2):262-3. PubMed ID: 19553017 [No Abstract] [Full Text] [Related]
9. Excessive acute migraine medication use and migraine progression. Sethi NK Neurology; 2009 Sep; 73(9):738. PubMed ID: 19720985 [No Abstract] [Full Text] [Related]
10. Migraine and the Risk of Suicide. Aly Z; Rosen N; Evans RW Headache; 2016 Apr; 56(4):753-61. PubMed ID: 27028299 [TBL] [Abstract][Full Text] [Related]
11. An injection of meperidine and an anti-nausea agent such as promethazine or prochlorperazine. Campbell K Headache; 1992 Mar; 32(3):159. PubMed ID: 1348739 [No Abstract] [Full Text] [Related]
16. Once too many: Impact of emergency department opioid use on future health resource utilization among patients with migraine. VanderPluym JH Headache; 2021 Feb; 61(2):229-230. PubMed ID: 33638238 [No Abstract] [Full Text] [Related]
17. [Acute migraine medications and evolution from episodic to chronic migraine]. Haag G MMW Fortschr Med; 2009 Feb; 151(6):41, 43. PubMed ID: 19432251 [No Abstract] [Full Text] [Related]
18. Increased adverse effects of opiates in migraine patients. Panconesi A; Anselmi B; Franchi G Cephalalgia; 1995 Apr; 15(2):159-60. PubMed ID: 7641253 [No Abstract] [Full Text] [Related]
19. Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study. Lipton RB; Buse DC; Friedman BW Neurology; 2021 Apr; 96(14):686. PubMed ID: 33820845 [No Abstract] [Full Text] [Related]
20. Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study. Minen MT Neurology; 2021 Apr; 96(14):685. PubMed ID: 33820844 [No Abstract] [Full Text] [Related] [Next] [New Search]